Filing Flows › BillionToOne (BLLN) › How it makes money
How BillionToOne (BLLN) makes money
BillionToOne (BLLN) made $123M of revenue in the third quarter 2026 (Q3 2026), +47% from a year earlier. Prenatal brought in $104M (85%); Oncology brought in $17.1M (14%); Clinical trial support and other services brought in $1.6M (1%). Of every dollar of revenue, 71¢ was left as gross profit, 9¢ was left as operating profit, 14¢ was left as net earnings.
Drawing the Sankey…
Revenue by segment, Q3 2026
| Segment | Revenue | Share | Q/Q | Y/Y |
|---|---|---|---|---|
| Prenatal | $104M | 84.8% | +11% | +41% |
| Oncology | $17.1M | 13.9% | +25% | +96% |
| Clinical trial support and other services | $1.6M | 1.3% | +7% | +115% |
Where each dollar of revenue goes
| Line | Q3 2026 | % of revenue |
|---|---|---|
| Revenue | $123M | 100.0% |
| Cost of revenue | $35.8M | 29.1% |
| Gross profit | $87.1M | 70.9% |
| Operating expenses | $76.1M | 61.9% |
| Operating profit | $11.0M | 9.0% |
| Income tax | $1K | 0.0% |
| Net earnings | $17.4M | 14.1% |
| Operating cash flow | $12.5M | 10.2% |
| Free cash flow | $8.6M | 7.0% |
Revenue, quarter by quarter
| Quarter | Revenue | Y/Y |
|---|---|---|
| Q3 2026 | $123M | +47% |
| Q2 2026 | $109M | +64% |
| Q1 2026 | $108M | +84% |
| Q4 2025 | $96.1M | +113% |
| Q3 2025 | $83.5M | +117% |
From BillionToOne's 10-Q filed Nov 4, 2026 (on EDGAR).
Questions
How does BillionToOne make money?
BillionToOne (BLLN) made $123M of revenue in the third quarter 2026 (Q3 2026), +47% from a year earlier. Prenatal brought in $104M (85%); Oncology brought in $17.1M (14%); Clinical trial support and other services brought in $1.6M (1%). Of every dollar of revenue, 71¢ was left as gross profit, 9¢ was left as operating profit, 14¢ was left as net earnings.
What is BillionToOne's biggest business?
Prenatal: $104M in the third quarter 2026, 85% of revenue, +41% from a year earlier.
What is BillionToOne's profit margin?
Net earnings were $17.4M, 14.1% of revenue, in the third quarter 2026; the operating margin was 9.0%.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.